Please login to the form below

Not currently logged in

WebMD set to acquire Aptus Health

Transaction includes Aptus' Univadis, EngagedMedia and Tomorrow Networks


Aptus Health

WebMD, an Internet Brands company providing health information services, has entered into an agreement to acquire digital health engagement solutions specialist Aptus Health. 

The acquisition includes Aptus’ core brand Univadis. This is Aptus’ global information and education platform delivering medical news, conference and research updates and thought leader education to four million healthcare professionals in 91 countries across the globe.

The addition of Aptus’ Univadis to WebMD’s Medscape franchise will help develop the reach of Medscape as a leading global source of clinical news, health information, education and point-of-care tools for healthcare professionals worldwide. Medscape and Medscape Education are part of the WebMD health corporation.

“Univadis strengthens our commitment to deliver best-in-class content and tools to millions of physicians worldwide,” said Jeremy Schneider (pictured below), senior vice president and group general manager of WebMD Global.

jeremy Schneider

Jeremy Schneider

“With Univadis, we deepen our connection to local markets, extend our reach to HCP audiences and increase our value to customers," he added.

The transaction also includes Aptus’ EngagedMedia, an integrated mobile messaging platform supporting patient engagement and adherence. In addition to this, Aptus’ Tomorrow Networks, which offers data-driven, location-based mobile advertising and marketing solutions driven by consumer behaviour, is also part of the deal.

Aptus Health is based in Reading, Massachusetts, US and is wholly owned by Merck/MSD. Aptus Health will continue to operate as an independent subsidiary of WebMD and the companies will integrate and build on products, platforms and services.

“Aptus Health is highly complementary to WebMD’s existing professional and consumer brands, making it an excellent addition to our platforms,” said Bob Brisco, CEO of WebMD.

“Together, we can leverage our combined strengths to extend our reach and engagement to healthcare professionals, patients and consumers,” he added.

The acquisition is expected to complete in October, with the terms of the deal remaining undisclosed.

Article by
Lucy Parsons

1st October 2019

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...